Gaborone, Botswana — Botswana and an American biotech firm, Ginkgo Bioworks, have partnered to conduct pathogen surveillance at the country’s entry points. Health officials say the proactive move is meant to safeguard public health as the world faces emerging disease threats.
Botswana introduced mpox screening last month for travelers at its entry points.
In a statement Wednesday, Ministry of Health spokesperson Christopher Nyanga said a pathogen-monitoring program is critical to detecting…
Read more on AllAfrica.com
South Africa Today Africa – Southern Africa Botswana News























